NCT01781429: A trial that was reported late by BioMed Valley Discoveries, Inc
This trial has reported, although it was 229 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01781429 |
|---|---|
| Title | Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 31, 2013 |
| Completion date | Feb. 28, 2018 |
| Required reporting date | Feb. 28, 2019, midnight |
| Actual reporting date | Oct. 15, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 229 |